Depsides and depsidones
Search Within Results
1
–
2
of
2
results
1
Medchemexpress LLC Sor-C13 Tfa | 99.3% | 1565.81 (free acid) | 5 MG
SOR-C13 TFA is a carboxy-terminal truncated peptide that acts as a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel associated with malignancy and poor prognosis in breast cancer. This peptide exhibits anticancer activity and is intended for research use only.
- High-affinity TRPV6 antagonist
- IC50 value of 14 nM against TRPV6
- Demonstrated anticancer activity
- Effectively inhibits tumor growth in vivo
- White to off-white solid appearance
- Soluble in H2O and DMSO at 100 mg/mL (with ultrasonic)
- Recommended storage conditions for powder: -80°C for 2 years, -20°C for 1 year
- Recommended storage conditions in solvent: -80°C for 6 months, -20°C for 1 month
2
Medchemexpress LLC SOR-C13 TFA | 1187852-48-7 | 99.3% | 1565.81 (free acid) | 50 MG
SOR-C13 TFA is a carboxy-terminal truncated peptide that acts as a high-affinity TRPV6 antagonist, exhibiting an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel implicated in malignancy and poor prognosis in breast cancer. This compound has demonstrated anticancer activity.
- High-affinity TRPV6 antagonist with an IC50 of 14 nM.
- TRPV6 is associated with malignancy and poor prognosis in breast cancer.
- Exhibits anticancer activity.
- In vivo studies showed effective inhibition of tumor growth in female NOD/SCID mice with SKOV-3 cells at dosages of 400, 600, and 800 mg/kg (IP; daily; on days 1 to 12).
- Has been investigated in clinical trials for cancer and advanced malignant solid neoplasm.